XML 66 R46.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Segment Reporting (Details) | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2018 USD ($) | Sep. 30, 2017 USD ($) | Jun. 30, 2017 USD ($) | Jun. 30, 2018 USD ($) segment | Jun. 30, 2017 USD ($)
Segment reporting information |  |  |  |  |
Number of operating segments | segment |  |  |  | 2 |
Number of reportable segments | segment |  |  |  | 3 |
Net revenues | $ 46,708,000,000 |  | $ 45,685,000,000 | $ 92,401,000,000 | $ 90,199,000,000
Cost of revenue | 39,507,000,000 |  | 38,759,000,000 | 78,341,000,000 | 76,702,000,000
Gross profit | 7,201,000,000 |  | 6,926,000,000 | 14,060,000,000 | 13,497,000,000
Operating expenses |  |  | 4,809,000,000 |  | 9,587,000,000
Operating profit (loss) | (1,587,000,000) |  | 2,117,000,000 | 359,000,000 | 3,910,000,000
Goodwill, impairment loss | 3,921,000,000 | $ 0 | 135,000,000 | 3,921,000,000 | 135,000,000
Pharmacy Services Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Net revenues, retail co-payments | 2,800,000,000 |  | 2,700,000,000 | 6,100,000,000 | 5,800,000,000
Retail/LTC Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Goodwill, impairment loss |  |  |  | 3,921,000,000 |
Loss on disposal |  |  |  | 86,000,000 |
Retail/LTC Segment | Operating profit |  |  |  |  |
Segment reporting information |  |  |  |  |
Restructuring Charges |  |  | 6,000,000 |  | 205,000,000
Rx Crossroads |  |  |  |  |
Segment reporting information |  |  |  |  |
Goodwill, impairment loss |  |  | 135,000,000 |  | 135,000,000
LTC reporting unit |  |  |  |  |
Segment reporting information |  |  |  |  |
Goodwill, impairment loss | 3,900,000,000 |  |  | 3,900,000,000 |
LTC reporting unit | Operating profit |  |  |  |  |
Segment reporting information |  |  |  |  |
Goodwill, impairment loss | 3,900,000,000 |  |  | 3,900,000,000 |
Operating Segments | Pharmacy Services Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Net revenues | 33,247,000,000 |  | 32,325,000,000 | 65,465,000,000 | 63,548,000,000
Cost of revenue |  |  | 30,868,000,000 |  | 61,009,000,000
Gross profit | 1,495,000,000 |  | 1,457,000,000 | 2,633,000,000 | 2,539,000,000
Operating expenses |  |  | 345,000,000 |  | 670,000,000
Operating profit (loss) | 1,088,000,000 |  | 1,112,000,000 | 1,849,000,000 | 1,869,000,000
Operating Segments | Retail/LTC Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Net revenues | 20,672,000,000 |  | 19,554,000,000 | 41,104,000,000 | 38,895,000,000
Cost of revenue |  |  | 13,876,000,000 |  | 27,536,000,000
Gross profit | 5,912,000,000 |  | 5,678,000,000 | 11,828,000,000 | 11,359,000,000
Operating expenses |  |  | 4,250,000,000 |  | 8,498,000,000
Operating profit (loss) | (2,225,000,000) |  | 1,428,000,000 | (601,000,000) | 2,861,000,000
Operating Segments | Corporate Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Operating expenses |  |  | 234,000,000 |  | 455,000,000
Operating profit (loss) | (263,000,000) |  | (234,000,000) | (527,000,000) | (455,000,000)
Intersegment Eliminations |  |  |  |  |
Segment reporting information |  |  |  |  |
Net revenues | (7,211,000,000) |  | (6,194,000,000) | (14,168,000,000) | (12,244,000,000)
Cost of revenue |  |  | (5,985,000,000) |  | (11,843,000,000)
Gross profit | (206,000,000) |  | (209,000,000) | (401,000,000) | (401,000,000)
Operating expenses |  |  | (20,000,000) |  | (36,000,000)
Operating profit (loss) | (187,000,000) |  | (189,000,000) | (362,000,000) | (365,000,000)
Previously Reported |  |  |  |  |
Segment reporting information |  |  |  |  |
Cost of revenue |  |  | 38,750,000,000 |  | 76,684,000,000
Gross profit |  |  | 6,935,000,000 |  | 13,515,000,000
Operating expenses |  |  | 4,818,000,000 |  | 9,605,000,000
Operating profit (loss) |  |  | 2,117,000,000 |  | 3,910,000,000
Previously Reported | Operating Segments | Pharmacy Services Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Cost of revenue |  |  | 30,856,000,000 |  | 60,983,000,000
Gross profit |  |  | 1,469,000,000 |  | 2,565,000,000
Operating expenses |  |  | 334,000,000 |  | 646,000,000
Operating profit (loss) |  |  | 1,135,000,000 |  | 1,919,000,000
Previously Reported | Operating Segments | Retail/LTC Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Cost of revenue |  |  | 13,879,000,000 |  | 27,544,000,000
Gross profit |  |  | 5,675,000,000 |  | 11,351,000,000
Operating expenses |  |  | 4,264,000,000 |  | 8,529,000,000
Operating profit (loss) |  |  | 1,411,000,000 |  | 2,822,000,000
Previously Reported | Operating Segments | Corporate Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Operating expenses |  |  | 240,000,000 |  | 466,000,000
Operating profit (loss) |  |  | (240,000,000) |  | (466,000,000)
Previously Reported | Intersegment Eliminations |  |  |  |  |
Segment reporting information |  |  |  |  |
Cost of revenue |  |  | (5,985,000,000) |  | (11,843,000,000)
Gross profit |  |  | (209,000,000) |  | (401,000,000)
Operating expenses |  |  | (20,000,000) |  | (36,000,000)
Operating profit (loss) |  |  | (189,000,000) |  | (365,000,000)
Adjustments. |  |  |  |  |
Segment reporting information |  |  |  |  |
Cost of revenue |  |  | 9,000,000 |  | 18,000,000
Gross profit |  |  | (9,000,000) |  | (18,000,000)
Operating expenses |  |  | (9,000,000) |  | (18,000,000)
Adjustments. | Operating Segments | Pharmacy Services Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Cost of revenue |  |  | 12,000,000 |  | 26,000,000
Gross profit |  |  | (12,000,000) |  | (26,000,000)
Operating expenses |  |  | 11,000,000 |  | 24,000,000
Operating profit (loss) |  |  | (23,000,000) |  | (50,000,000)
Adjustments. | Operating Segments | Retail/LTC Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Cost of revenue |  |  | (3,000,000) |  | (8,000,000)
Gross profit |  |  | 3,000,000 |  | 8,000,000
Operating expenses |  |  | (14,000,000) |  | (31,000,000)
Operating profit (loss) |  |  | 17,000,000 |  | 39,000,000
Adjustments. | Operating Segments | Corporate Segment |  |  |  |  |
Segment reporting information |  |  |  |  |
Operating expenses |  |  | (6,000,000) |  | (11,000,000)
Operating profit (loss) |  |  | 6,000,000 |  | 11,000,000
Omnicare, Inc. | Retail/LTC Segment | Gross Profit |  |  |  |  |
Segment reporting information |  |  |  |  |
Acquisition related costs |  |  | 5,000,000 |  | 5,000,000
Omnicare, Inc. | Retail/LTC Segment | Operating profit |  |  |  |  |
Segment reporting information |  |  |  |  |
Integration related costs |  |  | $ 10,000,000 | 3,000,000 | $ 25,000,000
Aetna Acquisition | Corporate Segment | Operating profit |  |  |  |  |
Segment reporting information |  |  |  |  |
Business Combination Acquisition Related Costs And Integration Related Costs | $ 39,000,000 |  |  | $ 79,000,000 |

X
- Definition Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business acquisition costs and business integration costs, systems integration and conversion costs, and severance and other employee-related costs. + References No definition available. + Details
Name: | cvs_BusinessCombinationAcquisitionRelatedCostsAndIntegrationRelatedCosts
Namespace Prefix: | cvs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition A fixed fee that subscribers to a medical plan must pay for use of entity medical services covered by the plan. + References No definition available. + Details
Name: | cvs_CoPaymentRevenue
Namespace Prefix: | cvs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=84229725&loc=d3e1043-128460 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs. + References No definition available. + Details
Name: | us-gaap_BusinessCombinationIntegrationRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a),(d)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Gain (loss) from sale or disposal of an organization or integrated set of activities (for example, but not limited to, a partnership or corporation) engaged in providing a product or service in a commercial, industrial, or professional environment. + References No definition available. + Details
Name: | us-gaap_GainLossOnSaleOfBusiness
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillImpairmentLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_GrossProfit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References No definition available. + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. + References No definition available. + Details
Name: | us-gaap_NumberOfReportableSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. + References No definition available. + Details
Name: | us-gaap_OperatingExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLTCSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=cvs_RxCrossroadsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=cvs_LTCReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementScenarioAxis=us-gaap_ScenarioPreviouslyReportedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=cvs_OmnicareInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=cvs_GrossProfitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=cvs_AetnaAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |